Dr. Mathieu Bernier, MD

Claim this profile

Institut Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ)

Studies Stenosis
Studies Follicular Lymphoma
4 reported clinical trials
7 drugs studied

Affiliated Hospitals

Image of trial facility.
Institut Universitaire De Cardiologie Et De Pneumologie De Québec (IUCPQ)
Image of trial facility.
Institut Universitaire De Cardiologie Et De Pneumologie De Québec- Université Laval

Clinical Trials Mathieu Bernier, MD is currently running

Image of trial facility.

Transcatheter Valve Repair

for Mitral Regurgitation

This trial tests a new device called Edwards PASCAL that fixes leaky heart valves without surgery. It is for patients who can't have surgery or haven't improved with other treatments. The device helps the valve close better, stopping blood from leaking backward.
Recruiting1 award N/A9 criteria
Image of trial facility.

Heart Surgery

for Coronary Artery Disease

The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy (STICH3C) trial is a prospective, unblinded, international multi-center randomized trial of 754 subjects enrolled in approximately 45 centers comparing revascularization by percutaneous coronary intervention (PCI) vs. coronary artery bypass grafting (CABG) in patients with multivessel/left main (LM) coronary artery disease (CAD) and reduced left ventricular ejection fraction (LVEF). The primary objective is to determine whether CABG compared to PCI is associated with a reduction in all-cause death, stroke, spontaneous myocardial infarction (MI), urgent repeat revascularization (RR), or heart failure (HF) readmission over a median follow-up of 5 years in patients with multivessel/LM CAD and ischemic left ventricular dysfunction (iLVSD). Eligible patients are considered by the local Heart Team appropriate and amenable for non-emergent revascularization by both modes of revascularization. The secondary objectives are to describe the early risks of both procedures, and a comprehensive set of patient-reported outcomes longitudinally.
Recruiting1 award N/A4 criteria

More about Mathieu Bernier, MD

Clinical Trial Related6 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Mathieu Bernier, MD has experience with
  • Edwards PASCAL System
  • Evolut FX TAVR System
  • Medtronic Evolut PRO+ TAVR System
  • Optimal Medical Therapy
  • Abbott Mitraclip System
  • Revascularization By CABG
Breakdown of trials Mathieu Bernier, MD has run
Follicular Lymphoma
Aortic Valve Stenosis

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
What does Mathieu Bernier, MD specialize in?
Is Mathieu Bernier, MD currently recruiting for clinical trials?
Are there any treatments that Mathieu Bernier, MD has studied deeply?
What is the best way to schedule an appointment with Mathieu Bernier, MD?
What is the office address of Mathieu Bernier, MD?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security